Unlike the past situation, nowadays Chinese investors are sophisticated in reaching licensing agreements with overseas pharmaceutical companies while more and more due diligence is being done. In addition to regulatory compliance, ACCESTRA offers a comprehensive suite of licensing services for overseas pharmaceutical companies. We can assist in communications with your prospective licensing partner and conduct due diligence as well as post-agreement inspection.
Please contact us for more information about the following service:
- Due Diligence of Prospective Licensing Partners
- Prepare Materials for Licensing Partners
- Arrange and Assist Meetings & Negotiations for Licensing Partnerships
- Post-agreement Inspection and Guidance on Implementation